Strategic advisory across sectors where policy outcomes shape business performance.
Integrated strategies to navigate governmental policy, regulatory complexity, and high-stakes decision-making.
In-depth legislative tracking and strategic analysis to anticipate shifts in the political landscape.
Developing comprehensive roadmaps to effectively navigate complex legislative and regulatory environments and advance strategic objectives.
Direct representation and strategic engagement with key decision-makers in Congress and the Executive Branch.
Building broad-based coalitions, fostering public support, and providing rapid response to protect reputation and navigate high-stakes scrutiny.
Strategic council on PAC development, compliance, and political giving strategies to strengthen engagement and maximize organizational influence.
Expert analysis of policy developments shaping markets, industries, and regulatory outcomes.
Over the weekend, U.S.–Canada trade negotiations broke down at the eleventh hour, and 50% Section 338 tariffs on roughly $20 billion of Canadian goods officially took effect at 12:01 a.m....
On August 11, 2026, the U.S. Food and Drug Administration (FDA) will publish in the Federal Register a proposed rule, “Substances Generally Recognized as Safe” (Docket No. FDA-2025-N-3262), that would fundamentally restructure...
The Senate has taken an initial step toward advancing significant new sanctions legislation targeting Russia and countries that continue to purchase Russian energy products. On July 28, the Senate voted 86–12...